FDA Seeks Input On Opioid Blister Pack Requirements, Potential Burdens

FDA is considering how it could go about requiring certain opioids to be dispensed in unit-of-dose, or blister, packaging and is seeking input from stakeholders, the agency announced in the Federal Register Friday (May 30). The agency lays out its proposed plan for rolling out the requirements but also seeks input on: the potential advantages and downsides of mandatory blister packaging, the logistical challenges with implementing the requirements, how much time would be needed for drug sponsors to satisfy...